Please provide your email address to receive an email when new articles are posted on . Lung nodule evaluations are crucial when working proactively against lung cancer, but some patients face ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. a leading data-driven diagnostic solutions company with a focus in lung disease, recently published data from three clinical studies, which found ...
Pulmonary Disease Expert, Dr. Susan Garwood, is Hosted by CHEST to Discuss Standardized Risk Assessment to Enhance Referral Patterns for Patients with Lung Nodules Due to more frequent chest imaging ...
Induction cetuximab (C) followed by C, paclitaxel (P), carboplatin (CP) and concurrent radiation (RT) for locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) The presence of a ...
(San Diego, Calif.--September 8, 2024, 10:05 a.m. PCT) – New data presented today reveals that the PanCan nodule management protocol demonstrates superior performance in triaging lung cancer screening ...
Visakhapatnam: Aninternational conference on Advanced Pulmonary Nodule Management was hosted here on Sunday. Organised by ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — A genomic sequencing classifier can help identify the probability of malignancy for patients with ...
About OncoCyte CorporationOncoCyte is a molecular diagnostics company providing actionable answers at critical decision points across the lung cancer care continuum, with the goal of improving patient ...
Pilot study of adding vincristine, topotecan, and cyclophosphamide to interval-compressed chemotherapy in newly diagnosed patients with localized Ewing sarcoma family of tumors: A Children's Oncology ...
Subsolid nodules (SSN) can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance. Conservative management of SSN will reduce unnecessary surgery and ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced a webinar to discuss biomarkers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results